BCM
OCEA

Beryl Capital Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Beryl Capital Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-673,674
Closed -$6.79M – 81
2022
Q1 		$6.79M Hold
673,674
– – 0.41% 89
2021
Q4 		$6.73M Buy
+673,674
New +$6.73M 0.35% 103

Other funds holding OCEA

SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Beryl Capital Management's OCEA Position: Q2 2022 in Review

Beryl Capital Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2022, closing a stake of 673,674 shares — an estimated $6.79M sold.

Beryl Capital Management first reported a position in OCEA in Q4 2021 and held it in 2 quarters. The position peaked at $6.79M in Q1 2022. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2022.

  • Beryl Capital Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Beryl Capital Management sold 673,674 Ocean Biomedical, Inc. Common Stock shares in Q2 2022, an estimated $6.79M.
  • Beryl Capital Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Beryl Capital Management's Ocean Biomedical, Inc. Common Stock position peaked at $6.79M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.